Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth: An Emerging Driver Transforming The Emphysema Treatment Market Landscape

The Emphysema Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Emphysema Treatment Market?
The Emphysema Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Emphysema Treatment Market?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10807

What Are the Different Emphysema Treatment Market Segments?
The emphysema treatment market covered in this report is segmented -

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Are the Primary Drivers Shaping the Emphysema Treatment Market?
The increasing incidence of chronic obstructive pulmonary disease (COPD), which includes disorders like emphysema and chronic bronchitis, is forecasted to stimulate the expansion of the emphysema treatment market. These treatments are critical in curtailing the progression of COPD as they aim to alleviate symptoms, restore pulmonary function, and delay the furtherance of the disease. For instance, reports from the Australian Institute of Health and Welfare (AIHW), a health-focused body from Australia, indicated in June 2024 that around 638,000 individuals, or 2.5% of the Australian populace, were living with COPD in 2022. By 2023, the proportion of COPD cases had increased to represent 3.6% of the overall disease burden, contributing to half of the total burden associated with respiratory conditions. Moreover, in 2022, COPD was to blame for 7,691 deaths, translating to 29.6 deaths per 100,000 people, and making up 4.0% of the total number of deaths nationwide. Hence, the escalating frequency of chronic obstructive pulmonary disease (COPD) cases is a significant driver of the emphysema treatment market.

Which Companies Are Leading in the Emphysema Treatment Market?
Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

What Are the Major Trends Shaping the Emphysema Treatment Market?
In the competitive emphysema market, leading corporations are developing less invasive procedures to gain leverage. These procedures cause minimal disruption to the body's normal structures and stand as an alternative to standard surgical procedures. For example, in January 2022, Adena Health System, a healthcare company based in the US, introduced a technique called Zephyr Valve surgery. This less invasive procedure is designed to help patients with lung hyperinflation, which is a common issue seen in cases of emphysema and COPD. The new method involves the insertion of tiny, one-way Zephyr Valves into the lungs' airways using a bronchoscope. These valves aid in the release of excess air trapped in the lungs, halting further air accumulation and allowing the healthier sections of the lung to expand, resulting in improved breathing.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

What Are the Top Revenue-Generating Geographies in the Emphysema Treatment Market?
North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Emphysema Treatment Market?
2. What is the CAGR expected in the Emphysema Treatment Market?
3. What Are the Key Innovations Transforming the Emphysema Treatment Industry?
4. Which Region Is Leading the Emphysema Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.